Bionano genomics hosts day 2 of 2022 symposium with new research demonstrating how ogm detects known and novel variants in hematologic malignancies

San diego, jan. 11, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, hosted the second day of 2022 symposium, the company's premiere event showcasing ogm research applications across key clinical areas of constitutional genetic disease, hematologic malignancies, solid tumors and ogm combined with next-generation sequencing (ngs).
BNGO Ratings Summary
BNGO Quant Ranking